gemcitabine hydrochloride

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 122111-03-9

Where It Comes From

30 FDA-registered drug labelers
Accord Healthcare Inc.
Armas Pharmaceuticals Inc.
Avyxa Pharma, LLC
BluePoint Laboratories
BSP Pharmaceuticals S.p.A.
Corden Pharma GmbH
Dr. Reddy's Laboratories Limited
Emcure Pharmaceuticals Limited
Evonik Corporation
Farmhispania S.A.
Fresenius Kabi USA, LLC
Gland Pharma Limited
Hetero Labs Limited
Hikma Pharmaceuticals USA Inc.
Hospira, Inc.
Ingenus Pharmaceuticals, LLC
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Laurus Labs Limited
Meitheal Pharmaceuticals Inc.
MSN Laboratories Private Limited
Mylan Institutional LLC
NorthStar Rx LLC
Sagent Pharmaceuticals
SciAnda (Changshu) Pharmaceuticals, Ltd.
ScinoPharm Taiwan Ltd.
SHILPA PHARMA LIFESCIENCES LIMITED
Sicor de Mexico S.A. de C.V
SUN PHARMACEUTICAL INDUSTRIES, INC.
Teyro Labs Private Limited
VALARY LAB PRIVATE LIMITED

Why It Matters

Sectors
Health
Downstream Uses

Appears in 3 drug and cosmetic product listings (FDA).

  • Gemcitabine
  • Gemcitabine hydrochloride
  • Avgemsi
FDA Shortage Status
No Shortage
Shortage History
to be discontinued

Gemcitabine Hydrochloride Injection

09/11/2025

Chemical Identity

CAS122111-03-9
PubChem CID60749
DTXSIDDTXSID3047849
FormulaC9H12ClF2N3O4
Mol. Weight299.66 g/mol
SMILESC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)(F)F.Cl

Data Sources

607492026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/gemcitabine hydrochloride/cids/JSON

Archive: data/sources/pubchem_name/gemcitabine hydrochloride.json

CAS 122111-03-92026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

CAS 122111-03-92026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json